Low Risk Setup
Astrazenca was underperforming the markets. Recently the stock has taken support at previous pivot low and resistance turned support. Low risk entry available for high risk reward
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。